Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
—
3.30%
Grew
—
—
Grew
—
1 Year
Score—
Net Growth3.30%
Net TrendGrew
Net Income Consistency—
Rev Growth—
Rev TrendGrew
Revenue Consistency—
All Time
—
-319.20%
33%
—
-88.67%
67%
—
All Time
Score—
Net Growth-319.20%
Net Trend33%
Net Income Consistency—
Rev Growth-88.67%
Rev Trend67%
Revenue Consistency—
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-11 | $ 0.00 | — |
5 Years2021-08-12 | $ 9.95 | -100.00% |
All Time2021-08-26 | $ 15.21 | -100.00% |
| Period | Last Price2026-08-11 | 5 Years2021-08-12 | All Time2021-08-26 |
|---|---|---|---|
| Price | $ 0.00 | $ 9.95 | $ 15.21 |
| Return | — | -100.00% | -100.00% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2024 | $ 162K | -$ 34M | $ 25M |
| 2023 | $ 0.00 | -$ 35M | $ 18M |
| 2022 | $ 3M | -$ 12M | $ 26M |
| IPO2021 | $ 1M | $ 15M | $ 49M |
Explore beyond EFTR
You're looking at Effector Therapeutics Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
